| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/29/2009 | US20090269833 Using sterospecific carboxylesterase variant for bioremediation of pyrethroids; eliminating or reducing the concentration of a pyrethroid pesticide in a sample |
| 10/29/2009 | US20090269800 Device and method for processing cell samples |
| 10/29/2009 | US20090269799 Method of determining a complete blood count and a white blood cell differential count |
| 10/29/2009 | US20090269798 Method and system for selecting chemotherapeutic agents |
| 10/29/2009 | US20090269797 strains of zymomonas mobilis for fermentation of biomass |
| 10/29/2009 | US20090269796 Methods of detecting and treating myocardial ischemia and myocardial infarction |
| 10/29/2009 | US20090269795 Mutant alpha4betadelta GABAA receptor and methods of treating anxiety or irritability |
| 10/29/2009 | US20090269794 Screening method for compound inhibiting development or progression of familial amyotrophic lateral sclerosis and diagnostic method for familial amyotrophic lateral sclerosis |
| 10/29/2009 | US20090269793 Compounds and Kits for the Detection and the Quantification of Cell Apoptosis |
| 10/29/2009 | US20090269792 Acetaminophen assay |
| 10/29/2009 | US20090269788 Method for detecting microorganism |
| 10/29/2009 | US20090269784 Protein engineering of monoacylglycerol lipase (mgll) |
| 10/29/2009 | US20090269775 Prognostic markers for classifying colorectal carcinoma on the basis of expression profiles of biological samples |
| 10/29/2009 | US20090269774 Evaluation of eosinophilic esophagitis |
| 10/29/2009 | US20090269773 Methods of determining the health status of an individual |
| 10/29/2009 | US20090269772 Systems and methods for identifying combinations of compounds of therapeutic interest |
| 10/29/2009 | US20090269771 Method of sequencing and mapping target nucleic acids |
| 10/29/2009 | US20090269770 Methods for evaluation prognosis and follow-up of drug treatment of psychiatric diseases or disorders |
| 10/29/2009 | US20090269769 Drug Discovery Methods Involving A Preclinical, In Vitro Isolated Gastrointestinal Epithelial Stem Cell-Like Progenitor Cell System |
| 10/29/2009 | US20090269768 Detection of high grade dysplasia in cervical cells |
| 10/29/2009 | US20090269767 Microfluidic chip devices and their use |
| 10/29/2009 | US20090269766 Nucleic acid amplification in the presence of modified randomers |
| 10/29/2009 | US20090269765 Compositions And Methods For Detection Of Small Molecules Using Dyes Derivatized with Analyte Responsive Receptors in a Chemiluminescent Assay |
| 10/29/2009 | US20090269764 Compositions and methods for detection of propionibacterium acnes nucleic acid |
| 10/29/2009 | US20090269763 Reprogramming a cell by inducing a pluripotent gene through RNA interference |
| 10/29/2009 | US20090269762 for detecting the presence of the transgene/genomic insertion region; for transgenic glyphosate tolerance; genetic engineering |
| 10/29/2009 | US20090269761 Genetic markers associated with age-related macular degeneration, methods of detection and uses thereof |
| 10/29/2009 | US20090269760 Enrichment methods for the detection of pathogens and other microbes |
| 10/29/2009 | US20090269759 Unnatural polymerase substrates that can sustain enzymatic synthesis of double stranded nucleic acids from a nucleic acid template and methods of use |
| 10/29/2009 | US20090269758 Diagnostic methods and kits for functional disorders |
| 10/29/2009 | US20090269757 Diagnosis kits and method for detecting cancer using polymorphic minisatellite |
| 10/29/2009 | US20090269756 Primer set for amplifying cyp2c19 gene, reagent for amplifying cyp2c19 gene containing the same, and the uses thereof |
| 10/29/2009 | US20090269755 Means and method for inducing exon-skipping |
| 10/29/2009 | US20090269754 Method of producing amplification product by pcr and usage thereof |
| 10/29/2009 | US20090269753 Genotyping for src-1 predicts for bone loss |
| 10/29/2009 | US20090269752 Method for selecting nucleic acids that bond with high-affinity to a target |
| 10/29/2009 | US20090269751 Dot1 histone methyltransferases as a target for identifying therapeutic agents for leukemia |
| 10/29/2009 | US20090269750 Marker and method for cancer diagnosis |
| 10/29/2009 | US20090269749 Method for high-throughput aflp-based polymorphism detection |
| 10/29/2009 | US20090269748 Identification of substances that inhibit nemo oligomerization |
| 10/29/2009 | US20090269747 Marker Genes Based on Amiodarone Treatment for Screening of Drug Inducing Toxicity and Screening Method Therefor |
| 10/29/2009 | US20090269746 Microsequencer-whole genome sequencer |
| 10/29/2009 | US20090269745 Rna extraction method and rna detection method |
| 10/29/2009 | US20090269744 Cancer detection method |
| 10/29/2009 | US20090269743 DNA Collection Sticker and Method for Isolating DNA From the Sticker |
| 10/29/2009 | US20090269742 Substrate for immobilizing biopolymer and method of immobilizing biopolymer by using the same |
| 10/29/2009 | US20090269741 Method for assessing traits selected from longissimus dorsi peak force, intramuscular fat, retail beef yield and net feed intake in bovine animals |
| 10/29/2009 | US20090269740 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells |
| 10/29/2009 | US20090269739 Kit for detection of telomerase reverse transcriptase nucleic acids |
| 10/29/2009 | US20090269738 Method of Screening for the Presence of a Genetic Defect Associated With Deep Venous Thrombosis |
| 10/29/2009 | US20090269737 Integrated non-homogeneous nucleic acid amplification and detection |
| 10/29/2009 | US20090269736 Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients |
| 10/29/2009 | US20090269735 Sample pretreatment solution for immunological test and method for using the same |
| 10/29/2009 | US20090269734 Method for determination of recognition specificity of virus for receptor sugar chain |
| 10/29/2009 | US20090269733 Devices and Methods for the Rapid Analysis of Pathogens in Biological Fluids |
| 10/29/2009 | US20090269732 Methods for Diagnosing Oncogenic Human Papillomavirus (HPV) |
| 10/29/2009 | US20090269731 E3-independent ubiquitinylation assay |
| 10/29/2009 | US20090269619 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
| 10/29/2009 | US20090269437 Glycerol channel gene and use thereof |
| 10/29/2009 | US20090269367 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles |
| 10/29/2009 | US20090269350 drug screening; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase |
| 10/29/2009 | US20090269344 Anti-EGFR antibody therapy based on an increased copy number of the EGFR gene in tumor tissues |
| 10/29/2009 | US20090269334 Biomarkers for graft rejection |
| 10/29/2009 | US20090269333 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 10/29/2009 | US20090269332 Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor |
| 10/29/2009 | US20090269326 nucleic acid molecule which codes for 6-O-sulfatase or N-sulfamidase; degrading monosaccharides or polysaccharides with the molecules; degrading glycosaminoglycan |
| 10/29/2009 | US20090269285 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
| 10/29/2009 | US20090269282 Methods for treating, preventing and diagnosing procine ttv infection |
| 10/29/2009 | US20090269280 Method for activation of transient receptor potential cation channel, subfamily a, member 1 using acetaldehyde |
| 10/29/2009 | US20090269279 Toxicology and Cellular Effect of Manufactured Nanomaterials |
| 10/29/2009 | US20090269278 18F, 11C, or deuterated fluoromethoxy-substituted 4-phenyl-4-benzoylaminomethylpiperindosulfonyl compounds for diagnostic imaging |
| 10/29/2009 | DE102008020152A1 Verwendung von biologischen Photorezeptoren als direkt lichtgesteuerte Ionenkanäle Use of biological photoreceptors as directly light-gated ion channels |
| 10/29/2009 | DE10154290B4 Verfahren zum Nachweis Parodontitis und Karies assoziierter Bakterien A method for detecting periodontal disease and caries-associated bacteria |
| 10/29/2009 | CA2722484A1 Analysis of nucleic acid amplification curves using wavelet transformation |
| 10/29/2009 | CA2722446A1 Protein engineering of monoacylglycerol lipase (mgll) |
| 10/29/2009 | CA2722424A1 Cytological methods for detecting cancer |
| 10/29/2009 | CA2722396A1 Methods and apparatus for segregation of particles |
| 10/29/2009 | CA2722316A1 Gene expression profiling based identification of genomic signature of high-risk multiple myeloma and uses thereof |
| 10/29/2009 | CA2722043A1 Nucleic acid comprising chimeric gene derived from hepatitis c virus |
| 10/29/2009 | CA2721952A1 Retinal pigment epithelial stem cells |
| 10/29/2009 | CA2721536A1 Method for detecting chikungunya virus |
| 10/29/2009 | CA2719078A1 Antiviral therapy |
| 10/28/2009 | EP2112511A1 Method of screening candidate compounds for susceptibility to biliary excretion |
| 10/28/2009 | EP2112509A1 Centrosome-assay |
| 10/28/2009 | EP2112235A1 Compositions and methods for microRNA expression profiling of nasopharyngeal carcinoma |
| 10/28/2009 | EP2112234A2 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy |
| 10/28/2009 | EP2112233A1 Pyrophosphorolysis activated polymerization (PAP): application to allele-specific amplification and nucleic acid sequence determination |
| 10/28/2009 | EP2112232A1 Methods for extracting pathogen nucleic acid from a blood sample using aurintricarboxylic acid |
| 10/28/2009 | EP2112231A2 MarA family helix-turn-helix domains and methods of use |
| 10/28/2009 | EP2112230A2 Ribonucleotide tag nucleic acid detection |
| 10/28/2009 | EP2112229A2 Methods for identifying risk of breast cancer and treatments thereof |
| 10/28/2009 | EP2112228A1 Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent |
| 10/28/2009 | EP2112224A2 Development of novel germplasm using segregates from transgenic crosses |
| 10/28/2009 | EP2112222A1 Gene encoding guanine nucleotide exchange factor and gene product thereof |
| 10/28/2009 | EP2112166A2 Human monoclonal antibodies to CTLA-4 |
| 10/28/2009 | EP2112157A1 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 10/28/2009 | EP2111465A2 Reagents and methods for detecting cyp2c9 polymorphisms |
| 10/28/2009 | EP2111464A1 Reporter unit for detection of target molecules using polymerisable substrate |
| 10/28/2009 | EP2111463A1 Methods and devices for diagnosis of appendicitis |
| 10/28/2009 | EP2111462A2 Medium for detecting and/or identifying bacteria |